Related Experiment Video

Updated: Aug 21, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

[A new vaccine concept: polysaccharide conjugate vaccines]

M Moreau1

  • 1Laboratoires Pasteur Mérieux Connaught, Marcy l'Etoile, France.

Annales Pharmaceutiques Francaises
|July 31, 1999
PubMed

Insights

Polysaccharide conjugate vaccines offer improved protection for infants by converting T-independent antigens into T-dependent ones, enhancing immunogenicity against bacterial infections.

Area of Science:

  • Vaccinology and immunology
  • Bacterial pathogenesis
  • Pediatric infectious diseases

Context:

  • Traditional polysaccharide vaccines are less effective in infants due to their immature immune systems.
  • Polysaccharide conjugate vaccines represent a significant advancement in pediatric vaccinology.
  • Existing conjugate vaccines have demonstrated high efficacy in preventing bacterial infections.

Purpose:

  • To review the development and efficacy of polysaccharide conjugate vaccines.
  • To highlight the immunological advantages of conjugate vaccines over plain polysaccharide vaccines in infants.
  • To discuss the potential of new conjugate vaccines, such as those against Streptococcus pneumoniae.

Summary:

  • Polysaccharide-based vaccines elicit a B cell-mediated response, which is insufficient for protecting infants.
  • Conjugating polysaccharides to carrier proteins transforms T-independent antigens into T-dependent antigens, improving immune response.
  • The success of Haemophilus influenzae type b conjugate vaccines demonstrates the potential of this approach, with a worldwide vaccination program aiming for eradication.

Impact:

  • Polysaccharide conjugate vaccines have revolutionized the prevention of bacterial infections in infants and young children.
  • The development of conjugate vaccines has led to significant reductions in disease burden and mortality.
  • Ongoing research and development promise further advancements in combating bacterial pathogens through conjugate vaccine technology.

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...